
Gencor’s PEA shows pain-reducing effects against acute menstrual cramping
Gencor’s palmitoylethanolamide (PEA) ingredient, Levagen+, has been found to reduce acute dysmenorrhea in its “first-ever clinical study” specific to menstrual pain.
News, Analysis & Insights on Nutrition, Supplements, and Health
Gencor’s palmitoylethanolamide (PEA) ingredient, Levagen+, has been found to reduce acute dysmenorrhea in its “first-ever clinical study” specific to menstrual pain.
See new developments from health and nutrition brands across Asia-Pacific, including GNC’s return to the Singapore market, CJ Bioscience’s gut microbiome test launch, Korea Ginseng Corporation using red ginseng for blood sugar control and more.